Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Short sellers increased their bets against the broader healthcare sector in February vs. January, and Moderna remained the ...

Also: Deeper looks at Microsoft, Tesla (and Musk) and ways to broaden your investment horizons and lower your risk.

Key Challenges Despite the market's upward trajectory, there are notable challenges. Late-stage diagnoses due to early asymptomatic conditions, the high cost of treatments, and limited specialist ...